Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 1, Issue 3
December 2025
Blood Immunology & Cellular Therapy Cover Image for Volume 1, Issue 3

Table of Contents

CELLULAR IMMUNOTHERAPY

Delay in CAR-T from single-case agreements: real-world impact on treatment and outcomes in at least twice-refractory DLBCL
Matthew J. Gromowsky,Christopher R. D’Angelo,James O. Armitage,R. Gregory Bociek,Radowan Elnair,Valerie K. Shostrom,Julie M. Vose,Matthew A. Lunning
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Impact of body mass index on anti-BCMA chimeric antigen receptor T-cell therapy outcomes in multiple myeloma
Ruth Choa,Kevin Miller,Advait Joshi,Cole Minsky,Samuel S. Han,Alexis Barselau,Andrew Yee,Andrew Branagan,Benjamin Puliafito,Matthew Frigault,Noopur Raje,Diana Cirstea
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patients
Shruthi Suryaprakash,Yilun Sun,Dinesh Keerthi,Amr Qudeimat,Ali Suliman,Aimee C. Talleur,Esther Obeng,Ewelina Mamcarz,Renee Madden,Rebecca Epperly,Senthil V. Bhoopalan,Swati Naik,Caitlin C. Zebley,M. Paulina Velasquez,Paula Arnold,Li Tang,Stephen Gottschalk,Brandon M. Triplett,Akshay Sharma
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Predicting infection risk following CAR-T using the bedside CAR-HEMATOTOX score: performance in an Australian cohort
Gemma K. Reynolds,Mark R. Dowling,Sara Vogrin,Olivia C. Smibert,Benjamin W. Teh,Mary Ann Anderson,Karin Thursky,Simon J. Harrison,Monica A. Slavin
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Viral vector-free generation of orthogonal IL-2–responsive CAR T cells through gene editing of IL-2 and its receptor
Qian Zhang,Yihao Wu,Jingyi Yang,Kevin Zhou,Eric Nigel Ebenezer Anand Manoharan,Tyra Wentz,Leon Su,Alvin Yu,Hong-Yi Wang,Laurakay Bruhn,Israel Steinfeld,Nicolas Gonzalez,Edward Z. Song,Yunlin Zhang,Morgan E. Hresko,Daniel E. Ryan,Nils W. Engel,Selene Nunez-Cruz,Carl H. June,K. Christopher Garcia,Michael C. Milone
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Utility of neurotoxicity investigations in CD19 and BCMA CART recipients with ICANS
Lauren N. Scott,Benjamin Hane,William Wesson,Pilar Thangwaritorn,Raeef Rahman,Marc Hoffmann,Forat Lutfi,Zahra Mahmoudjafari,Sunil Abhyankar,Dinesh Pal Mudaranthakam,Muhammad Umair Mushtaq,Joseph McGuirk,Al-Ola Abdallah,Muhammad Mahdi Nashatizadeh,Nausheen Ahmed
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

GENE THERAPY

Lipid nanoparticle Fas gene therapy suppresses autoimmune lymphoproliferative syndrome in mice
Dakota B. Poschel,Zainab Tiamiyu,Priscilla Redd,Alyssa Merting,Natasha Savage,Kebin Liu
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

IMMUNOBIOLOGY

Modeling Vγ9Vδ2 T-cell exhaustion in vitro: phenotypic and functional insights for immunotherapy
Morgane Chauvet,Joseph Léger,Mélanie Laurent-Blond,Claire Pecqueur,Christelle Harly,Dorothée Bourges,Emmanuel Scotet
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

NONCELLULAR IMMUNOTHERAPY

Selinexor-based treatments are associated with increased expression of T-cell activation markers in multiple myeloma
Yubin Kang,Jadee L. Neff,Andrea Ellero,William R. Jeck,Cristina Gasparetto,Xiaobei Wang,Xufeng Chen,Zuowei Su,Christopher J. Walker
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Streptavidin-drug conjugates streamline optimization of antibody-based hematopoietic stem cell transplant conditioning
Aditya R. Yelamali,Ezhilarasi Chendamarai,Julie K. Ritchey,Michael P. Rettig,John F. DiPersio,Stephen P. Persaud
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Low-dose nivolumab and lenalidomide in relapsed/refractory Hodgkin lymphoma: a single-arm phase 2 trial
Anu Korula,Uday Kulkarni,Arun Kumar Arunachalam,Phaneendra Datari,Aswin Anand Pai,Sumith Mathew,Fouzia Nambiatheyil Aboobacker,Sushil Selvarajan,Sharon Lionel,Kavitha Lakshmi,Aby Abraham,Biju George,Poonkuzhali Balasubramanian,Vikram Mathews
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
  • Cover Image

    Cover Image

    issue cover

    Heat map shows the differences in effects on CD3+ protein expression by exportin 1 inhibitor selinexor (SEL) cotherapy and the response status. Columns represent the z score–scaled normalized expressions of the indicated proteins in each posttreatment sample. Annotation tracks indicate the SEL combination therapy arm and patient response status at the time of biopsy. See the article by Kang et al.

All Issues

Advertisement intended for health care professionals

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 

Advertisement intended for health care professionals

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals